We isolated 11 nonconjugative plasmids mediating resistance to aminoglycoside antibiotics, including gentamicin, from Pseudomonas aeruginosa strains. Their genetic properties were investigated in both P. aeruginosa and Escherichia coli transformants. The plasmid molecular weights ranged from 11 x 106 to 24 x 106. A low level or complete absence of gentamicin resistance was observed when these plasmids were introduced into E. coli, but gentamicin resistance was restored when the plasmids were transferred back to P. aeruginosa from E. coli. Aminoglycoside-modifying enzyme activity was detected in P. aeruginosa harboring these plasmids, but was absent or greatly reduced in E. coli strains. This lack of expression may explain the observed decrease in aminoglycoside resistance.
Plasmids isolated from Pseudomonas aeruginosa have been classified into 11 incompatibility groups. Most of the conjugative plasmids are nontransmissible to Escherichia coli strains, except for plasmids of the P-1 or P-3 group (12) . Three reasons for this nontransferability to E. coli can be postulated: (i) nontransmissibility owing to some differences in cell surface structure; (ii) no replication of the plasmids after transmission to E. coli strains; and (iii) failure of resistance gene expression in the E. coli system. Some of the plasmids mobilized to E. coli by the presence of P-1 group plasmids can replicate by themselves in that host (12, 13, 16) . In contrast, many plasmids are incapable of replication in E. coli, except by recombination with the mobilizing plasmid (13, 20) .
Recently the isolation frequency of gentamicin-resistant P. aeruginosa strains has increased (3, 4, 14, 18, 21, 24, 26) . We have also isolated plasmids mediating gentamicin resistance and transferable by conjugation to a recipient P. aeruginosa strain in 20% of the 91 gentamicinresistant P. aeruginosa isolates from clinical specimens in Japan. Gentamicin-resistance plasmids which were transfer deficient were also found in 56% of the gentamicin-resistant strains. In this report, we examined the genetic properties of such nonconjugative plasmids mediating gentamicin resistance in P. aeruginosa and also in E. coli after being introduced by transformation.
MATERIALS AND METHODS Media. Heart infusion agar (Eiken Kagaku Co., Tokyo, Japan) and peptone water were used for the determination of drug resistance. Peptone water consisted of 1,000 ml of distilled water, 5 g of NaCI, and 10 g of peptone. For the assay of sulfanilamide resistance, A-glucose agar or semisynthetic medium was used. A-glucose agar consisted of medium A (6) without sodium citrate but contained 0.008% bromothymol blue, 1.5% agar, and 0.1% glucose. Semisynthetic medium consisted of 1,000 ml of medium A, 2 g of Casamino Acids, 10 mg of tryptophane, 2 mg of nicotinic acid, 10 mg of thiamine, 2 g of glucose, and 15 g of agar. BTB agar used for the selection of transformants and transconjugants consisted of nutrient broth (10 g of beef extract, 10 g of peptone, and 3 g of NaCl in 1,000 ml of distilled water) supplemented with 0.008% bromothymol blue and 1.5% agar. L-broth (22) was used for the preparation of competent cells for transformation. Penassay broth (Difco Laboratories, Detroit, Mich.) was used as the medium for conjugation. Medium B consisted of 10 g of peptone, 2 g of yeast extract, 8 g of Na2HPO4 12H20, 2 g of KH2PO4, 1.2 g of (NH4)2SO4, 2 g of glucose, and 0.4 g of MgSO4 in 1,000 ml of distilled water.
Bacterial strains. A total of 91 gentamicin-resistant strains of P. aeruginosa were isolated from clinical specimens at 12 hospitals geographically dispersed in Japan. P. aeruginosa ML5019 (rifampin-resistant mutant of ML5018), ML5066 (nalidixic acid-resistant mutant of PA02142), MUA561 (iifampin-resistant mutant of Ps1008), and E. coli ML4905 (rifampin-resistant mutant of X1037) were used as the recipients for plasmids. ML5018 was a Rec-mutant of PA02142 (17) . Both PA02142 and Ps1OO8 (Leu-Arg-Ilv-His-Trp-) were gifts from H. Matsumoto (Shinshu University, Matsumoto, Japan), whereas E. coli K12 X1037 (17) (17) . Alternatively, a small-scale purification technique (2) was used. The cleared lysate was prepared by sodium dodecyl sulfate-alkaline treatment, and plasmid DNA was precipitated with ethanol after removal of chromosomal DNA fragments.
Agarose gel electrophoresis. Plasmid DNA was subjected to electrophoresis at 100 mA for 1.5 h, using horizontal 0.6% agarose gels in TEAS buffer (pH 8.0) containing 50 mM Tris, 20 mM sodium acetate, 2 mM EDTA, and 18 mM NaCl. After the DNA was stained with ethidium bromide, the gels were photographed with UV light.
Estimation of molecular weight. Plasmid DNAs were visualized under an electron microscope according to the method of Yamagishi et al. (27) . The doublestranded replicative form of fd DNA with a size of 6.4 kilobase pairs was used as the internal standard in electron microscopic observations (1) . The molecular weight of plasmid DNA was estimated as the mean value of about 20 molecules.
Assay of aminoglycoside-modifyng enzymes. Preparation of cell-free extract and assay of aminoglycosidemodifying enzymes were carried out by the slightly modified procedure described previously (24) . For the bioassay of enzymes, 0.15 ml of S-30 fraction was supplied to the mixture containing 0.05 ml of coenzyme (20 mM ATP or 1 mM acetyl coenzyme A), 0.05 ml of 20 mM MgCI2, and 0.2 ml of 0.2 M buffer (sodium acetate, pH 6; Tris-malate, pH 7; Tris-hydrochloride, pH 8). The reaction mixture was incubated at 37°C for 6 h and then stopped by heating at 100°C for 1 min. The residual activity of antibiotics in the reaction mixture was determined by the cup method with Bacillus subtilis ATCC 6633 as a test organism. Radioisotope assay was carried out with [1-14C]acetyl coenzyme A (10 ,uCi/ml), [y-32P]ATP (50 ,Ci/ml), or [8-14C] ATP (10 ,Ci/ml). The reaction mixture consisted of 30 ,ul of S-105 fraction (10 mg of protein per ml), 10 ,ul of 20 mM MgCl2, 10 ,ul of 1 mM drug, and 10 ,u1 of coenzyme. The reaction was carried out at 37°C for 2 h.
RESULTS
Isolation of plasmids mediating gentamicin resistance. We could isolate conjugative plasmids mediating gentamicin resistance from 22 of 91 gentamicin-resistant P. aeruginosa strains. We selected 14 gentamicin-resistant strains from the remaining 69 strains without conjugative plasmids owing to differences in their resistance patterns, clinical sources, or both. We isolated plasmid DNA from these 14 strains and transferred the DNA to P. aeruginosa ML5019 by transformation. We obtained 11 nonconjugative plasmids mediating gentamicin resistance from nine strains and none from the remaining five strains. Seven of these plasmids were randomly selected for further studies. Their resistance patterns and molecular weights are shown in Table 1 .
We transposed Tnl (9) (Table 2) .
When plasmid DNA was isolated from either P. aeruginosa or E. coli transformants and visualized by agarose gel electrophoresis, the molecular weight of each plasmid was found to be the same in both bacteria (Fig. 1) EcoRI was also the same in both bacterial hosts.
Assay of aminoglycoside-modifying enzymes.
Activities of aminoglycoside-modifying enzymes were determined by using the extracts of plasmid-bearing P. aeruginosa ML5019 and plasmid-bearing E. coli ML4905. At least two enzymes were found in P. aeruginosa transformants by bioassay, and the substrate profile of enzymes is shown in Table 3 . In contrast, no enzyme activity could be found in E. coli transformants by bioassay.
The results of the incorporation of [14C]acetyl coenzyme A into gentamicin Cla or kanamycin A are also shown in Table 3 . Activity of acetyltransferase in E. coli extract was less than 9o of that in P. aeruginosa extract. coli.
e -, Host bacteria without plasmid. Introducing these plasmids to E. coli strains by transformation, they could replicate stably, but their gentamicin resistance was hardly detectable, whereas resistance to carbenicillin or mercuric chloride was normally expressed in the E. coli strains. However, the level of gentamicin resistance was restored to the same level as in the original P. aeruginosa strains when the plasmids were transferred back to P. aeruginosa from E. coli transformants. The molecular weight of each plasmid was found to be the same in both bacteria. These results indicated that deletion of plasmid DNA did not occur in E. coli after transformation from P. aeruginosa. Similarly, deletion of plasmid DNA did not take place after transformation back from E. coli transformants to P. aeruginosa.
These plasmids conferred upon P. aeruginosa resistance to aminoglycoside antibiotics such as kanamycin, dibekacin, netilmicin, tobramycin, and sisomicin in addition to gentamicin, but did not mediate amikacin, fortimicin, and lividomycin resistance. We detected at least two aminoglycoside-modifying enzymes in P. aeruginosa transformants, but hardly any enzyme activity could be detected in E. coli transformants. In the latter case, the absence of enzyme activity was paralleled by lack of resistance to gentamicin. The decreased gentamicin resistance level in E. coli transformants may be due to the lack of enzyme synthesis.
Not only plasmids described in this paper but also other P. aeruginosa plasmids mediating gentamicin resistance which can replicate in E. coli have been reported to confer a lower level of gentamicin resistance in E. coli than P. aeruginosa (19, 26) . When the level of gentamicin resistance is expressed as the ratio of MIC values of an R+ host to that of an R-host to compare the relative level of resistance, the relative value for P. aeruginosa strains carrying pMS106, pMS112, pMG1 (18) , pMG2 (18), RPL11 (13), R151 (13), Rmsl49 (13) , or R1033 (26) is 16, 64, 40, 40, 32, 32, 16, and 330, respectively, and that for E. coli carrying the same plasmids is 1, 4, >8, >8, 8, 4, 2, and 125, respectively. The resistance level of these plasmids, except for R1033, is similar to that of the plasmids described in this paper. Although the precise mechanisms of aminoglycoside resistance caused by enzymatic modification are not completely known, the rate of aminoglycoside uptake relative to the rate of drug modification seems to be an important variable (7) . A difference in the rate of this uptake could be one of the reasons for the observed host dependency of the gentamicin resistance level. In addition, a decreased resistance could be due to other factors, such as reduced or absent modifying enzyme synthesis.
That phenotypic properties of plasmids or chromosomal genes change in different species of bacteria has been described previously. Hedges et al. (11) pointed out an impediment in the expression of P. aeruginosa tryptophan synthase genes in E. coli. A low level of gentamicin resistance in Vibrio cholerae compared with E. coli (10) and a lack of expression of E. coli genes in B. subtilis have also been reported (8) . In these cases and in the results described in this paper, the mechanisms have not been elucidated, but some defect at the transcriptional level in different hosts is suggested.
